Elekta AB (publ) (EKTAY)

Market Cap	2.09B
Revenue (ttm)	1.66B
Net Income (ttm)	93.77M
Shares Out	n/a
EPS (ttm)	0.25
PE Ratio	22.30
Forward PE	n/a
Dividend	0.15 (2.64%)
Ex-Dividend Date	Sep 9, 2024

Volume	23,500
Open	5.47
Previous Close	5.45
Day's Range	5.44 - 5.47
52-Week Range	5.44 - 8.37
Beta	1.11
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, suc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 4,718
• Stock Exchange: OTCMKTS
• Ticker Symbol: EKTAY

Financial Performance

In 2024, Elekta AB's revenue was 18.12 billion, an increase of 7.41% compared to the previous year's 16.87 billion. Earnings were 1.30 billion, an increase of 38.07%.

Financial numbers in SEK